✦ LIBER ✦

Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: A diagnostic challenge

✍ Scribed by Amy Rapkiewicz; Rimma Gorokhovsky; Eduardo Farcon; Kasturi Das

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 259 KB
Volume: 36
Category: Article
ISSN: 8755-1039
DOI: 10.1002/dc.20814

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemohormonal therapy of metastatic pros

Chemohormonal therapy of metastatic prostate cancer. A pilot study

✍ Dennis L. Citrin; Thomas F. Hogan; Thomas E. Davis 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 2 views

Total androgen blockade with the use of

Total androgen blockade with the use of orchiectomy and nilutamide (anandron) or placebo as treatment of metastatic prostate cancer

✍ R. A. Janknegt; Anandron International Study Group 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB 👁 1 views

Ixabepilone, mitoxantrone, and prednison

Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy : A phase 2 study of the department of defense prostate cancer clinical trials consortium

✍ Andrea L. Harzstark; Jonathan E. Rosenberg; Vivian K. Weinberg; Jeremy Sharib; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 1 views

Immunoreactivity of prostate-specific an

Immunoreactivity of prostate-specific antigen in male breast carcinomas: Two examples of a diagnostic pitfall in discriminating a primary breast cancer from metastatic prostate carcinoma

✍ Raj K. Gupta 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 3 views

Prostatic-specific antigen (PSA) is regarded as a specific marker secreted by normal and neoplastic acinar epithelial cells of the prostate gland; its detection by immunocytochemistry has been accepted as an indication of metastatic prostate cancer. This is ascribed to the commonly held belief that

A comparison of the quality of life of p

A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

✍ Harry W. Herr; Alice B. Kornblith; Ursula Ofman 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

The prognostic value of hemoglobin chang

The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer : A Multivariate Analysis of Southwest Oncology Group Study 8894

✍ Tomasz M. Beer; Catherine M. Tangen; Lisa B. Bland; Maha Hussain; Bryan H. Goldm 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB